The Wistar Institute names cancer center deputy director
Click Here to Manage Email Alerts
Maureen E. Murphy, PhD, has been appointed deputy director of Ellen and Ronald Caplan Cancer Center at The Wistar Institute.
“I am honored and excited to throw all my energy into achieving Wistar’s strategic goals,” Murphy said in a press release. “I look in amazement at Wistar’s progress these past 10 years, both scientifically and financially. We have a growing endowment, immense scientific impact, a newly revitalized culture of collaboration, the commitment of our leadership to provide new technology to support ambitious biomedical research, and the spearheading of education programs from high schooler to nontraditional trainee to junior faculty.”
Murphy — who joined The Wistar Institute in 2011 — is the Ira Brind endowed professor. She has served as program leader of the molecular and cellular oncogenesis program, as well as associate vice president for faculty affairs. She also has served as principal investigator of the training grant in cancer biology, which provides support for top Wistar trainees.
Murphy is recognized for her research related to p53. She has studied the effect of genetic variants of p53 on cancer risk and therapy response, with a focus on genetic variants among individuals of African descent.
Murphy also has played a key role in pharmacologic targeting of HSP70 for cancer therapy, particularly metastatic melanoma and colorectal cancer.
“I cannot be more grateful to Maureen for her unwavering commitment, dedication and support of our institute and cancer center,” Dario C. Altieri, MD, president and CEO of The Wistar Institute and director of Ellen and Ronald Caplan Cancer Center, said in the release. “I very much look forward to working with her to chart our vision for the future of the cancer research enterprise at Wistar in sync with our recently released 5-year strategic plan and associated philanthropic campaign.”
Read more about
Click Here to Manage Email Alerts